Literature DB >> 25024097

Smoking is associated with a worse self-reported health status in patients with psoriatic arthritis: data from a Swedish population-based cohort.

Ann Bremander1, Lennart T H Jacobsson, Stefan Bergman, Emma Haglund, Sofia Löfvendahl, Ingemar F Petersson.   

Abstract

The aim was to study possible associations between smoking habits and self-reported clinical features in a large population-based cohort of patients with psoriatic arthritis (PsA). All subjects with PsA who had sought health care in the period 2003-2007 were identified using a regional health-care register. In 2009, all those identified who were 18 years of age or more (n = 2,003) were sent a questionnaire with questions on smoking, health-related quality of life [EuroQol five-dimension (EQ-5D)questionnaire], function [Health Assessment Questionnaire (HAQ)], pain, fatigue, and global health. We performed age- and sex-adjusted regression analysis to compare health status outcomes in never and ever smokers. Altogether, 1,185 subjects (59%) returned the questionnaire. Mean age was 57 years (SD 13.5), and 58% were women; 38% were never smokers and 62% were ever smokers. Mean age at disease onset was 38.2 years (SD 13.2) and 41.2 years (SD 13.6), respectively (p = 0.001). In age- and sex-adjusted data, ever smokers reported worse EQ-5D (p = 0.009); worse reports of global health (p = 0.01), pain (p = 0.01), and fatigue (p = 0.04); and a higher number of painful body regions (p = 0.04) compared to never smokers. In this population-based PsA cohort, patients who were ever smokers reported worse health status than never smokers. Besides being a possible result of a worse PsA in ever smokers, impaired health status could also be an effect of unstudied comorbidities. Further longitudinal studies are needed to gain a better understanding of cause and effect. However, smoking cessation should be recommended because of general health considerations as well as disease-specific issues.

Entities:  

Mesh:

Year:  2014        PMID: 25024097     DOI: 10.1007/s10067-014-2742-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

1.  EuroQol--a new facility for the measurement of health-related quality of life.

Authors: 
Journal:  Health Policy       Date:  1990-12       Impact factor: 2.980

Review 2.  Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidence.

Authors:  Hanna Johnsson; Iain B McInnes; Naveed Sattar
Journal:  Ann Rheum Dis       Date:  2012-01-30       Impact factor: 19.103

3.  Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than non-smokers of the same serological group.

Authors:  G Westhoff; R Rau; A Zink
Journal:  Rheumatology (Oxford)       Date:  2008-04-04       Impact factor: 7.580

4.  Smoking and risk of incident psoriasis among women and men in the United States: a combined analysis.

Authors:  Wenqing Li; Jiali Han; Hyon K Choi; Abrar A Qureshi
Journal:  Am J Epidemiol       Date:  2012-01-12       Impact factor: 4.897

5.  Chronic musculoskeletal pain, prevalence rates, and sociodemographic associations in a Swedish population study.

Authors:  S Bergman; P Herrström; K Högström; I F Petersson; B Svensson; L T Jacobsson
Journal:  J Rheumatol       Date:  2001-06       Impact factor: 4.666

6.  Relationship between smoking and patient-reported measures of disease outcome in ankylosing spondylitis.

Authors:  Derek L Mattey; Sarah R Dawson; Emma L Healey; Jonathan C Packham
Journal:  J Rheumatol       Date:  2011-10-01       Impact factor: 4.666

7.  Age-related correlation between antioxidant enzymes and DNA damage with smoking and body mass index.

Authors:  Parvathi Kumara Reddy Thavanati; Kodanda Reddy Kanala; Aurora Escoto de Dios; Jose Maria Cantu Garza
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-04       Impact factor: 6.053

8.  Risk factors for psoriasis: A case-control study.

Authors:  Slavenka Jankovic; Milena Raznatovic; Jelena Marinkovic; Janko Jankovic; Natasa Maksimovic
Journal:  J Dermatol       Date:  2009-04-28       Impact factor: 4.005

Review 9.  Effects of tobacco smoke on immunity, inflammation and autoimmunity.

Authors:  Yoav Arnson; Yehuda Shoenfeld; Howard Amital
Journal:  J Autoimmun       Date:  2009-12-29       Impact factor: 7.094

Review 10.  Neuronal nicotinic receptors as analgesic targets: it's a winding road.

Authors:  Iboro C Umana; Claire A Daniele; Daniel S McGehee
Journal:  Biochem Pharmacol       Date:  2013-08-12       Impact factor: 5.858

View more
  11 in total

1.  Inflammatory dietary pattern and incident psoriasis, psoriatic arthritis, and atopic dermatitis in women: A cohort study.

Authors:  Alanna C Bridgman; Abrar A Qureshi; Tricia Li; Fred K Tabung; Eunyoung Cho; Aaron M Drucker
Journal:  J Am Acad Dermatol       Date:  2019-02-21       Impact factor: 11.527

2.  Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from Spain.

Authors:  Juan Carlos Torre-Alonso; Loreto Carmona; Mireia Moreno; Eva Galíndez; Jesús Babío; Pedro Zarco; Luis Linares; Eduardo Collantes-Estevez; Manuel Fernández Barrial; Juan Carlos Hermosa; Pablo Coto; Carmen Suárez; Raquel Almodóvar; Jesús Luelmo; Santos Castañeda; Jordi Gratacós
Journal:  Rheumatol Int       Date:  2017-04-07       Impact factor: 2.631

3.  Smoking Cigarettes and Consuming Alcohol in Patients with Psoriasis.

Authors:  Eldina Malkic Salihbegovic; Nermina Kurtalic; Esed Omerkic
Journal:  Mater Sociomed       Date:  2021-03

4.  Smoking cessation intervention for reducing disease activity in chronic autoimmune inflammatory joint diseases.

Authors:  Ida K Roelsgaard; Bente A Esbensen; Mikkel Østergaard; Silvia Rollefstad; Anne G Semb; Robin Christensen; Thordis Thomsen
Journal:  Cochrane Database Syst Rev       Date:  2019-09-02

5.  Self-reported health-related quality of life (HRQoL) and factors affecting HRQoL among individuals with health insurance in Iran.

Authors:  Ali Kazemi Karyani; Arash Rashidian; Sarar Emamgholipour Sefiddashti; Ali Akbari Sari
Journal:  Epidemiol Health       Date:  2016-10-26

6.  The effect of an intensive smoking cessation intervention on disease activity in patients with rheumatoid arthritis: study protocol for a randomised controlled trial.

Authors:  Ida Kristiane Roelsgaard; Thordis Thomsen; Mikkel Østergaard; Robin Christensen; Merete Lund Hetland; Søren Jacobsen; Lena Andersen; Hanne Tønnesen; Silvia Rollefstad; Anne Grete Semb; Bente Appel Esbensen
Journal:  Trials       Date:  2017-11-28       Impact factor: 2.279

Review 7.  The Impact of Comorbidity on Patient-Reported Outcomes in Psoriatic Arthritis: A Systematic Literature Review.

Authors:  Juan D Cañete; Jose Antonio Pinto Tasende; Francisco José Rebollo Laserna; Susana Gómez Castro; Rubén Queiro
Journal:  Rheumatol Ther       Date:  2020-04-08

8.  Management of Psoriatic Arthritis: Turkish League Against Rheumatism (TLAR) Expert Opinions.

Authors:  Kemal Nas; Erkan Kiliç; Remzi Çevik; Hatice Bodur; Şebnem Ataman; Figen Ayhan; Özgür Akgül; Ayşen Akinci; Zuhal Altay; Erhan Çapkın; Abdullah Zübeyir Dağli; Tuncay Duruöz; Gülcan Gürer; Feride Göğüş; Yeşim Garip; Cahit Kaçar; Ayhan Kamanli; Ece Kaptanoğlu; Taciser Kaya; Hilal Kocabaş; Erhan Ali Özdemirel; Sumru Özel; İlhan Sezer; İsmihan Sunar; Gürkan Yilmaz
Journal:  Arch Rheumatol       Date:  2018-05-21       Impact factor: 1.472

9.  Psoriatic arthritis: an evolving matter.

Authors:  Daniel Wendling
Journal:  RMD Open       Date:  2015-02-18

10.  Young patients with risk factors prevalent in the elderly - differences in comorbidity depending on severity of psoriasis: a nationwide cross-sectional study in Swedish health registers.

Authors:  Mohammadhossein Hajiebrahimi; Marie Linder; David Hägg; Ina Anveden Berglind; Sean McElligott; Valgard Sverrir Valgardsson; Reginald Villacorta; Anders Sundström
Journal:  Clin Epidemiol       Date:  2018-06-19       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.